Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Moodys
QuintilesIMS
Chubb
Mallinckrodt
Argus Health
Fuji
Harvard Business School
Accenture

Generated: April 24, 2018

DrugPatentWatch Database Preview

KETALAR Drug Profile

« Back to Dashboard

When do Ketalar patents expire, and what generic alternatives are available?

Ketalar is a drug marketed by Par Sterile Products and is included in one NDA.

The generic ingredient in KETALAR is ketamine hydrochloride. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ketamine hydrochloride profile page.
Drug patent expirations by year for KETALAR
Pharmacology for KETALAR
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Medical Subject Heading (MeSH) Categories for KETALAR
Synonyms for KETALAR
( inverted exclamation markA)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride
( inverted exclamation markA)-Ketamine hydrochloride
(+-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride
(+-)-Ketamine hydrochloride
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone Hydrochloride
(+/-)-Ketamine hydrochloride
(+/-)-Ketamine hydrochloride, solid
100477-73-4
1867-66-9
2-(2-chlorophenyl)-2-(methylamino)-1-cyclohexanone hydrochloride
2-(2-CHLOROPHENYL)-2-(METHYLAMINO)-CYCLOHEXANONE HCL
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one hydrochloride
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one;hydrochloride
2-(2-chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride
2-(2-CHLOROPHENYL)-2-METHYLAMINO-CYCLOHEXAN-1-ONE HYDROCHLORIDE
2-(METHYLAMINO)-2-(2-CHLOROPHENYL)CYCLOHEXANONE HYDROCHLORIDE
42551-62-2
79499-52-8
81771-21-3
867K669
96448-41-8
A813079
AB02117
AC1L26R3
AK115529
AKOS005287313
AN-50011
API0003068
BC203880
BG0226
C-17269
C07843
C13H16ClNO.HCl
Calipsol
CC-05450
CHEBI:650657
CHEMBL1714
CI 581
CI-581
CL 369
CL-369
CL369
CN-52,372-2
CN-52372-2
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, hydrochloride
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, hydrochloride, (+-)-
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, hydrochloride, (+-)-
D00711
DB-044614
DEA No. 7285
DTXSID4040137
EC 217-484-6
EINECS 217-484-6
FT-0633887
H753
HSDB 2180
I14-2818
Kalipsol
Ketalar (TN)
Ketamine chloride
KETAMINE HCL
KETAMINE HYDROCHLORIDE
Ketamine hydrochloride (JP17/USP)
Ketamine hydrochloride [USAN:JAN]
Ketamine hydrochloride [USAN:USP:JAN]
Ketamine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Ketamine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Ketanarkon
Ketanest
Ketaset
Ketavet
Ketavet (Veterinary)
Ketavet 100
Ketolar
LS-57302
LT00160033
MCULE-9619764916
Narketan hydrochloride
NSC-116131
NSC116131
OR062794
OR210518
PMI-150
Q-201266
SCHEMBL26999
VCMGMSHEPQENPE-UHFFFAOYSA-N
Vetalar

US Patents and Regulatory Information for KETALAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products KETALAR ketamine hydrochloride INJECTABLE;INJECTION 016812-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products KETALAR ketamine hydrochloride INJECTABLE;INJECTION 016812-002 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products KETALAR ketamine hydrochloride INJECTABLE;INJECTION 016812-003 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Julphar
Dow
Mallinckrodt
Cipla
Farmers Insurance
Fish and Richardson
Healthtrust
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.